Bank Of America Corp Enanta Pharmaceuticals Inc Transaction History

Bank Of America Corp

$1.06 Trillion
Q1 2024

A detailed history of Bank Of America Corp transactions in Enanta Pharmaceuticals Inc stock. As of the latest transaction made, Bank Of America Corp holds 516,366 shares of ENTA stock, worth $6.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

516,366

Previous 12,260 4111.79%

Holding current value

$6.7 Million

Previous $115,000 7739.13%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$10.08 - $17.46 $5.08 Million - $8.8 Million	504,106 Added 4111.79%	516,366 $9.02 Million
Q4 2023 Feb 14, 2024	SELL	$8.18 - $10.78 $355,519 - $468,520	-43,462 Reduced 78.0%	12,260 $115,000
Q2 2023 Aug 14, 2023	SELL	$20.68 - $39.85 $3.45 Million - $6.65 Million	-166,986 Reduced 74.98%	55,722 $1.19 Million
Q1 2023 May 12, 2023	BUY	$38.82 - $54.59 $6.5 Million - $9.14 Million	167,431 Added 302.89%	222,708 $9.01 Million
Q4 2022 Feb 10, 2023	BUY	$40.77 - $53.73 $463,554 - $610,910	11,370 Added 25.9%	55,277 $2.57 Million

Q3 2022 Nov 14, 2022	BUY	$48.29 - $71.27 $1.51 Million - $2.23 Million	31,273 Added 247.53%	43,907 $2.28 Million
Q2 2022 Aug 12, 2022	SELL	$38.13 - $76.93 $957,596 - $1.93 Million	-25,114 Reduced 66.53%	12,634 $597,000
Q1 2022 May 16, 2022	BUY	$56.06 - $74.11 $1.07 Million - $1.42 Million	19,154 Added 103.01%	37,748 $2.69 Million
Q4 2021 Feb 08, 2022	BUY	$60.19 - $97.37 $618,331 - $1 Million	10,273 Added 123.46%	18,594 $1.39 Million
Q3 2021 Nov 15, 2021	BUY	$41.02 - $58.65 $45,286 - $64,749	1,104 Added 15.3%	8,321 $472,000
Q2 2021 Sep 13, 2021	BUY	$43.76 - $53.11 $315,815 - $383,294	7,217 New	7,217 $317,000

Others Institutions Holding ENTA

# of Institutions

108

Shares Held

21.7M

Call Options Held

9.4K

Put Options Held

3.3K

View Full List

About ENANTA PHARMACEUTICALS INC

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $269M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

More about ENTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Enanta Pharmaceuticals Inc Transaction History